Health
Inhaled steroid ciclesonide suppresses SARS-CoV-2 replication in vitro – News-Medical.Net
A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
With the COVID-19 pandemic, the world has suffered hundreds of thousands of deaths and tens of millions of cases. In order to contain this outbreak, new and already approved drugs are being tested. A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv* in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
Steroids have been repurposed for the treatmen…
-
Business13 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business9 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News10 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business7 hours ago3 reasons to buy Nvidia stock like there’s no tomorrow